Durvalumab as Consolidation Therapy in Post-Multimodal Interventional Treatment for Patients with Advanced Solid Tumors: A Preliminary Study

Table 1

Patient data characteristics.

No. of patients	Age	Gender	Stage of the cancer
1	64	Male	IIIC
2	49	Male	IVA
3	38	Female	0
4	32	Male	IIB
5	54	Male	IV
6	49	Female	IIIA
7	60	Female	IIA
8	42	Female	I
9	31	Male	IIA
10	48	Female	IV
11	62	Male	IVA
12	58	Female	IIIB